Activity of tethered human immunodeficiency virus 1 protease containing mutations in the flap region of one subunit

European Journal of Biochemistry

Volumn 244, Issue 1, 1997, Pages 235-241

  Tözsér, József ^a   Yin, Fay H ^b   Cheng, Yin Shyun E ^b   Bagossi, Péter ^a   Weber, Irene T ^c   Harrison, Robert W ^c   Oroszlan, Stephen ^d  

^a UNIVERSITY OF DEBRECEN   (Hungary)

^b DUPONT COMPANY   (United States)

^c THOMAS JEFFERSON UNIVERSITY   (United States)

^d Mammalian Genetics Laboratory   (United States)

Author keywords

Enzyme kinetics; Flap mutants; Human immunodeficiency virus protease; Oligopeptide substrate; Substrate specificity

Indexed keywords

PROTEINASE;

ARTICLE; ENZYME ACTIVITY; ENZYME ANALYSIS; ENZYME SUBUNIT; HUMAN IMMUNODEFICIENCY VIRUS 1; MOLECULAR MODEL; MUTANT; PRIORITY JOURNAL; SEQUENCE ANALYSIS;

EID: 0031042369     PISSN: 00142956     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1432-1033.1997.00235.x     Document Type: Article

References (41)

1. Mellors, J. V. (1996) Closing in on human immunodeficiency virus-1, Nat. Med. 2, 274-275.
2. Wlodawer, A. & Erickson, J. W. (1993) Structure-based inhibitors of HIV-1 protease, Annu. Rev. Biochem. 62, 543-585.
3. Gustchina, A. & Weber, I. T. (1990) Comparison of inhibitor binding in HIV-1 protease and in non-viral aspartic proteases: the role of the flap, FEBS Lett. 269, 269-272.
4. Rao, J. K. M., Erickson, J. W. & Wlodawer, A. (1991) Structural and evolutionary relationships between retroviral and eucaryotic aspartic proteinases, Biochemistry 30, 4663-4671.
5. Cheng, Y.-S. E., Yin, F. H., Foundling, S., Blomstrom, D. & Kettner, C. A. (1990) Stability and activity of human immunodeficiency virus protease: comparison of the natural dimer with a homologous, single-chain tethered dimer, Proc. Natl Acad. Sci. USA 87, 9660-9664.
6. Bhat, T. N., Baldwin, E. T., Liu, B., Cheng, Y.-S. E. & Erickson, J. W. (1994) Crystal structure of a tethered dimer of HIV-1 protease complexed with an inhibitor. Nat. Struct. Biol. 1, 552-556.
7. Weber, I. T. (1989) Structural alignment of retroviral protease sequences, Gene (Amst.) 85, 565-566.
8. Cheng, Y.-S. E., McGowan, M. H., Kettner, C. A., Schloss, J. V., Erickson-Viitanen, S. & Yin, F. H. (1990) High-level synthesis of recombinant HIV-1 protease and the recovery of active enzyme from inclusion bodies, Gene (Amst.) 87, 243-248.
9. Laemmli, U. K. (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4, Nature 227, 680-685.
10. Towbin, H., Staehelin, T. & Gordon, J. (1979) Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: Procedure and some applications, Proc. Natl Acad. Sci. USA 76, 4350-4354.
11. Copeland, T. D. & Oroszlan, S. (1988) Genetic locus, primary structure and chemical synthesis of human immunodeficiency virus protease, Gene Anal. Tech. 5, 109-115.
12. Bláha, I., Nemec, J., Tözsér, J. & Oroszlan, S. (1991) Synthesis of homologous peptides using fragment condensation: analogs of a HIV protease substrate, Int. J. Peptide Protein Res. 38, 453-458.
13. Tözsér, J., Bláha, I., Copeland, T. D., Wondrak, E. M. & Oroszlan, S. (1991) Comparison of the HIV-1 and HIV-2 proteinases using oligopeptide substrates representing cleavage sites in Gag and Gag-Pol polyproteins, FEBS Lett. 281, 77-80.
14. Zybarth, G., Kräusslich, H.-G., Partin, K. & Carter, C. (1994) Proteolytic activity of novel human immunodeficiency virus 1 protease proteins from a precursor with a blocking mutation at the N terminus of the PR domain, J. Virol. 68, 240-250.
15. Grobelny, D., Wondrak, E. M., Galardy, R. E. & Oroszlan, S. (1990) Selective phosphinate transition-state analogue inhibitors of the protease of human immunodeficiency virus, Biochem. Biophys. Res. Commun. 169, 1111-1116.
16. Schechter, I. & Berger, A. (1968) On the size of the active site in proteases. I. Papain, Biochem. Biophys. Res. Commun. 27, 157-172.
17. Weber, I. T., Tözsér, J., Wu, J., Friedman, D. & Oroszlan, S. (1993) Molecular model of equine infectious anemia virus protease and kinetic measurements for peptide substrates with single amino acid substitutions, Biochemistry 32, 3354-3362.
18. Sack, J. S. (1988) CHAIN - a crystallographic modeling program, J. Mol. Graph. 6, 224-225.
19. Jones, A. T. (1985) Interactive computer graphics: FRODO, Methods Enzymol. 115, 157-171.
20. Bagossi, P., Cheng, Y.-S. E., Oroszlan, S. & Tözsér, J. (1996) Activity of linked HIV-1 protease dimers containing mutations in the active site region, Protein Eng. 9, 997-1003.
21. Harrison, R. W. (1993) Stiffness and energy conservation in the molecular dynamics: an improved integrator, J. Comput. Chem. 14, 1112-1122.
22. Kräusslich, H.-G. (1991) Human immunodeficiency virus protease dimer as component of the viral polyprotein prevents particle assembly and viral infectivity, Proc. Natl Acad. Sci. USA 88, 3213-3217.
23. Phylip, L. H., Mills, J. S., Parten, B. F., Dunn, B. M. & Kay, J. (1992) Intrinsic activity of precursor forms of HIV-1 proteinase, FEBS Lett. 314, 449-454.
24. Wondrak, E. M., Louis, J. M. & Oroszlan, S. (1991) The effect of salt on the Michaelis Menten constant of the HIV-1 protease correlates with the Hofmeister series, FEBS Lett. 280, 344-346.
25. Baca, M. & Kent, S. B. H. (1993) Catalytic contribution of flap-substrate hydrogen bonds in HIV-1 protease explored by chemical synthesis, Proc. Natl Acad. Sci. USA 90, 11638-11642.
26. Hyland, L. J., Tomaszek, T. A. Jr & Meek, T. D. (1991) Human immunodeficiency virus-1 protease. 2. Use of pH rate studies and solvent kinetic isotope effects to elucidate details of chemical mechanism, Biochemistry 30, 8454-8463.
27. Polgár, L., Szeltner, Z. & Boros, I. (1994) Substrate-dependent mechanisms in the catalysis of human immunodeficiency virus protease, Biochemisty 33, 9351-9357.
28. Baboonian, C., Dalgleish, A., Bountiff, L., Gross, J., Oroszlan, S., Rickett, G., Smith-Burchnell, C., Troke, P. & Merson, J. (1991) HIV-1 protease is required for synthesis of pro-viral DNA, Biochem. Biophys. Res. Commun. 179, 17-24.
29. Loeb, D. D., Swanstrom, R., Everitt, L., Manchester, M., Stamper, S. E. & Hutchinson, C. A. III (1989) Complete mutagenesis of the HIV-1 protease, Nature 340, 397-400.
30. Moody, M. D., Pettit, S. C., Shao, W., Everitt, L., Loeb, D. D., Hutchinson, C. A. III & Swanstrom, R. (1995) A side chain at position 48 of the human immunodeficiency virus type-1 protease flap provides an additional specificity determinant, Virology 207, 475-485.
31. Swain, A. L., Miller, M. M., Green, J., Rich, D. H., Schneider, J., Kent, S. B. H. & Wlodawer, A. (1990) X-ray crystallographic structure of a complex between a synthetic protease of human immunodeficiency virus 1 and a substrate-based hydroxyethylamine inhibitor, Proc. Natl Acad. Sci. USA 87, 8805-8809.
32. Harrison, R. W. & Weber, I. T. (1994) Molecular dynamics simulations of HIV-1 protease with peptide substrate, Protein Eng. 7, 1353-1363.
33. Patterson, S., Gross, J., English, N., Stackpoole, A., Bedford, P. & Knight, S. C. (1995) CD4 expression on dendritic cells and their infection by human immunodeficiency virus, J. Gen. Virol. 76, 1155-1163.
34. Ott, D. E., Nigida, S. M. Jr. Henderson, L. E. & Arthur, L. O. (1995) The majority of cells are superinfected in a cloned cell line that produces high levels of human immunodeficiency virus 1 strain MN, J. Virol. 69, 2443-2450.
35. Rosé, J. R., Babé, L. M. & Craik, C. S. (1995) Defining the level of human immunodeficiency virus 1 (HIV-1) protease activity required for HIV-1 particle maturation and infectivity. J. Virol. 69, 2751-2758.
36. Winslow, D. L. & Otto, M. J. (1995) HIV protease inhibitors, AIDS (Phila) 9 (suppl. A), S183-S192.
37. Kozal, M. J., Shah, N., Shen, N., Yang, R., Fucini, R., Merigan, T. C., Richman, D. D., Morris, D., Hubbell, E., Chee, M. & Gingeras, T. R. (1996) Extensive polymorphism observed in HIV-1 clade B protease gene using high-density oligonucleotide arrays, Nat. Med. 2, 753-759.
38. Tisdale, M., Myers, R. E., Maschera, B., Parry, N. R., Oliver, N. M. & Blair, E. D. (1995) Cross-resistance analysis of human immunodeficiency virus 1 variants individually selected for resistance to five different protease inhibitors, Antimicrob. Agents Chemother. 39, 1704-1710.
39. Partaledis, J. A., Yamaguchi, K., Tisdale, M., Blair, E. E., Falcione, C., Maschera, B., Myers, R. E., Pazhanisamy, S., Futer, O., Cullinan, A. B., Stuver, C. M., Byrn, R. A. & Livingston, D. J. (1995) In vitro selection and characterization of human immunodeficiency virus 1 (HIV-1) isolates with reduced sensitivity to hydroxyethylamino sulfonamide inhibitors of HIV-1 aspartyl protease, J. Virol. 69, 5228-5235.
40. Jackobsen, H., Yasargil, K., Winslow, D. L., Craig, C., Kröhn, A., Duncan, I. B. & Mous, J. (1995) Characterization of human immunodeficiency virus 1 mutants with decreased sensitivity to protease inhibitor Ro 31-8959, Virology 206, 527-534.
41. Leis, J., Baltimore, D., Bishop, J. M., Coffin, J., Fleissner, E., Goff, S. P., Oroszlan, S., Robinson, H., Skalka, A. M., Temin, H. M. & Vogt, V. (1988) Standardized and simplified nomenclature for proteins common to all retroviruses. J. Virol. 62, 1808-1809.